Comment Submissions - Announcement of Additional Public Comment Period on Acetaminophen

This comment period was open from 11/29/2019 until 01/27/2020.

Notice

Carcinogen Identification Meeting Postponed and Announcement of Additional Public Comment Period

Comments

A Voice for Choice Advocacy

California Society of Interventional Pain Physicians

response_prop_65_csa_-_iii.pdf

Consumer Healthcare Products Association

chpa_supplemental_comments_1-27-20.pdf

Kenneth T. Furukawa, MD

MANDY ROBERTSON, MD

Phillip J. Richardson, M.D., M.B.A., F.A.S.A., C.P.E.

PL Developments

Updated: Health, medical, patient, and consumer advocates

110519_stakeholder_letter_urging_no_listing_for_apap_2.pdf

Yvonne Choong, Vice President, Health Policy, California Medical Association

2020-01-27_cma_ltr_acetaminophen.pdf